Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

2019-nCoV

- PMLiVE

FDA maintains COVID-19 therapeutics must meet a ‘gold standard’

Comes after President Trump called for expedited approval of potential treatments

- PMLiVE

Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace

A number of candidates begin trial testing

- PMLiVE

Germany’s coronavirus infections climb but deaths remain low

Experts debate ‘anomaly’ as other countries record higher death rates

- PMLiVE

EMA calls for pooled EU research into COVID-19 therapies

Asks for a harmonised methodology across member states

- PMLiVE

Lilly partners with Indiana State Health Department for coronavirus testing

Experts maintain that testing can curb the outbreak

- PMLiVE

Coronavirus disruption scuppers Curium Pharma sale

London-based private equity firm CapVest will wait for market to improve

- PMLiVE

COVID-19: Novel coronavirus remains stable on surfaces for hours

Researchers find virus stays on surfaces for several hours to days

- PMLiVE

UK biotech Synairgen to begin COVID-19 trial of lead candidate

Company enters the race to find a therapeutic as virus cases rise

- PMLiVE

Novartis launches $20m COVID-19 response fund

Financial grants will be issued to most impacted communities

- PMLiVE

Biogen joins COVID-19 efforts with $10m support fund

Funds will be used to address 'immediate critical needs'

- PMLiVE

First patients dosed with Moderna’s COVID-19 vaccine

More pharma players also join vaccine development efforts

- PMLiVE

UK ramps up measures to combat coronavirus spread

New advice encourages ‘social-distancing’ as cases expected to soar

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links